Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
Lixivaptan
ATK-00269
98.00%
168079-32-1
C27H21N3O2FCL
473.92594
Article number Size Operate
ATK-00269 10MG 10MG Inquiry
ATK-00269 25MG 25MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 168079-32-1 Appearance
Catalog NO ATK-00269 MDL Number
Molecular Formula C27H21N3O2FCL Molecular Weight 473.92594
Boiling Point 626.5°Cat760mmHg Melting Point
Flash Poin Density 1.32
Synonyms N-(3-Chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)phenyl)-5-fluoro-2-methylbenzamide;Benzamide,N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluo...;Benzamide,N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-;Lixivaptan;N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylBenzamide;N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide;UNII-8F5X4B082E;VPA-985;WAY-VPA-985;N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide;VPA 985;WAY-VPA 985;N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methyl-benzamide;5-fluoro-2-methyl-N-(4-(5H-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11H)-ylcarbonyl)-3-chlorophenyl)benzamide;CHEMBL49429;N-[3-Chloro-4-[10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl]phenyl]-5-fluoro-2-methylbenzamide;FT-0670828;VPA985;Benzamide, N-(3-chloro-4-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-;EX-A1129;N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbony)-3-chlorophenyl]-5-fluoro-2-methylbenzamide;N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide;GTPL2238;HMS3747A19;MFCD00937905;NS00068352;N-[4-(5H,11H-Benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)-3-chloro-phenyl]-5-fluoro-2-methyl-benzamide;PPHTXRNHTVLQED-UHFFFAOYSA-N;3-chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-10-ylcarbonyl)-1-(5-fluoro-2-methylphenylcarboxamido)benzene;N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide;SY225929;8F5X4B082E;N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methyl-benzamide;Q6659958;DTXSID00168472;VPA-985;WAY-VPA 985;Lixivaptan (USAN/INN);BDBM50065115;Lixar;NCGC00485402-01;BCP09167;Benzamide, N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-;3'-Chloro-5-fluoro-4'-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)-o-toluanilide;Lixivaptan (VPA-985);168079-32-1;BS-15602;2-chloro-6,7,8,9-tetrahydrobenzocyclohepten-5-one;CRTX 080;D04752;LIXIVAPTAN [WHO-DD];Lixivaptan [USAN];LIXIVAPTAN [MART.];LIXIVAPTAN [INN];HY-14185;Benzamide, N-(3-chloro-4-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-;;N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide;N-4-(3-chloro-4-(5H-pyrrolo(2,1-C)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide;DB06666;L001508;LIXIVAPTAN [VANDF];WAY VPA-985;AKOS022181388;CRTX080;LIXIVAPTAN [MI];CRTX-080;SCHEMBL1649340;CS-7512;Lixivaptan [...
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!